Search

Jill E Wykosky

age ~43

from Brookline, MA

Get Report
Also known as:
  • Jill Elaine Wykosky
  • Jill E Floyd
  • Jill Wykoski
  • Floyd E Jill
  • Jill Y
Related to:
Connected to:

Jill Wykosky Phones & Addresses

  • Brookline, MA
  • 748 Archer St, San Diego, CA 92109 • (858)2467805
  • La Jolla, CA
  • Freemansburg, PA
  • Winston Salem, NC
  • Hummelstown, PA
  • Pittsburgh, PA
  • 748 Archer St, San Diego, CA 92109

Work

  • Company:
    Ludwig institute for cancer research
    Jun 2008
  • Position:
    Postdoctoral fellow

Education

  • Degree:
    Ph.D.
  • School / High School:
    Wake Forest University
    2004 to 2008
  • Specialities:
    Molecular Medicine/Cancer Biology

Skills

Molecular Biology • Cell Biology • In Vivo • Oncology • Molecular Cloning • Western Blotting • Immunofluorescence • Microscopy • Signal Transduction • Microbiology

Industries

Pharmaceuticals

Resumes

Jill Wykosky Photo 1

Director, Head Of Gi Biology

view source
Location:
San Diego, CA
Industry:
Pharmaceuticals
Work:
Ludwig Institute for Cancer Research since Jun 2008
Postdoctoral Fellow
Wake Forest University - Winston-Salem, NC 2004 - 2008
Graduate Student
University of Pittsburgh 2000 - 2003
Undergraduate Researcher
Education:
Wake Forest University 2004 - 2008
Ph.D., Molecular Medicine/Cancer Biology University of Pittsburgh 1999 - 2003
B.S., Microbiology
Skills:
Molecular Biology
Cell Biology
In Vivo
Oncology
Molecular Cloning
Western Blotting
Immunofluorescence
Microscopy
Signal Transduction
Microbiology

Us Patents

  • Eph Receptor Tumor Biomarkers

    view source
  • US Patent:
    20060121539, Jun 8, 2006
  • Filed:
    Oct 21, 2005
  • Appl. No.:
    11/256684
  • Inventors:
    Waldemar Debinski - Winston-Salem NC, US
    Denise Gibo - Winston-Salem NC, US
    Jill Wykosky - Winston-Salem NC, US
  • Assignee:
    The Penn State Research Foundation - University Park PA
  • International Classification:
    G01N 33/574
    C07K 14/82
    C07K 16/30
  • US Classification:
    435007230, 530350000, 530388220
  • Abstract:
    Specific, differential expression of EphA2 in both GBM cells and human GBM tumors compared to normal brain are shown. EphA2 serves as a useful molecular marker for cancer in such areas as diagnosis and prognosis. In addition, EphA2 is used in the development of new therapeutics for tumors, such as molecularly targeted drug delivery.

  • Molecular Signature Of Cancer

    view source
  • US Patent:
    20090123371, May 14, 2009
  • Filed:
    Aug 29, 2008
  • Appl. No.:
    12/201662
  • Inventors:
    Waldemar Debinski - Winston-Salem NC, US
    Jill Wykosky - Winston-Salem NC, US
    Denise Gibo - Winston-Salem NC, US
  • Assignee:
    Wake Forest University Health Sciences - Winston-Salem NC
  • International Classification:
    A61K 51/08
    C07K 14/47
    A61K 39/385
    A61P 35/00
    A61K 49/14
    A61K 38/17
  • US Classification:
    424 169, 530350, 530402, 514 12, 4241931, 424 91
  • Abstract:
    The present invention provides compounds, compositions, and methods for detecting, diagnosing and treating cancers such as glioblastoma multiforme.

  • Molecular Signature Of Cancer

    view source
  • US Patent:
    20180243368, Aug 30, 2018
  • Filed:
    Apr 19, 2018
  • Appl. No.:
    15/957445
  • Inventors:
    - Winston-Salem NC, US
    Jill Wykosky - La Jolla CA, US
    Denise Mazess Herpai - Winston-Salem NC, US
  • International Classification:
    A61K 38/17
    A61K 49/00
    C07K 14/52
    A61K 38/45
    A61K 47/64
    A61K 47/68
    A61K 45/06
  • Abstract:
    The present invention provides compounds, compositions, and methods for detecting, diagnosing and treating cancers such as glioblastoma multiforme.

  • Molecular Signature Of Cancer

    view source
  • US Patent:
    20160193289, Jul 7, 2016
  • Filed:
    Feb 9, 2016
  • Appl. No.:
    15/018991
  • Inventors:
    - Winston-Salem NC, US
    Jill Wykosky - LaJolla CA, US
    Denise Mazess Herpai - Winston-Salem NC, US
  • International Classification:
    A61K 38/17
    A61K 47/48
    A61K 38/45
    A61K 38/20
  • Abstract:
    The present invention provides compounds, compositions, and methods for detecting, diagnosing and treating cancers such as glioblastoma multiforme.

  • Molecular Signature Of Cancer

    view source
  • US Patent:
    20130136692, May 30, 2013
  • Filed:
    Dec 3, 2012
  • Appl. No.:
    13/692324
  • Inventors:
    Wake Forest University Health Sciences - Winston-Salem NC, US
    Jill Wykosky - LaJolla CA, US
    Denise Gibo - Winston-Salem NC, US
  • Assignee:
    Wake Forest University Health Sciences - Winston-Salem NC
  • International Classification:
    C07K 14/705
    A61K 31/7088
    A61K 38/20
    A61K 39/395
    A61K 38/17
    A61K 45/06
  • US Classification:
    424 169, 530350, 530402, 435188, 530409, 514 75, 424 943, 424 852, 4241581
  • Abstract:
    The present invention provides compounds, compositions, and methods for detecting, diagnosing and treating cancers such as glioblastoma multiforme.

Facebook

Jill Wykosky Photo 2

Jill Wykosky

view source
Get Report for Jill E Wykosky from Brookline, MA, age ~43
Control profile